Rajeev Ramchand

Oct 8, 2024 | rand.org | Rajeev Ramchand

VA-delivered health care versus private sector care for veterans has generated a complicated debate. How do you envision this evolving over the next decade? Carrie Farmer Over 9 million veterans are enrolled in VA health care and receive care at hundreds of VA hospitals and thousands of outpatient clinics across the country. That demand has been growing for the last decade or so because of the aging veteran population and the influx of veterans who served after 9/11.

Feb 12, 2024 | rand.org | Melissa L. Finucane |Matthew Lee |Rajeev Ramchand

The purpose of the Survey of Trauma, Resilience, and Opportunity among Neighborhoods in the Gulf (STRONG) was to assess the long term well-being of residents of Gulf coast communities. Respondents were asked about dimensions of well-being including mental health, physical health, health care utilization, traumatic experiences, oil spill exposure, and alcohol use.

Oct 19, 2023 | rand.org | Rajeev Ramchand

This report is part of the RAND Corporation Testimony series. RAND testimonies record testimony presented by RAND associates to federal, state, or local legislative committees; government-appointed commissions and panels; and private review and oversight bodies. This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only.

Jun 12, 2023 | sfchronicle.com | Beau Kilmer |Rajeev Ramchand

Beau Kilmer, Rajeev RamchandJune 12, 2023 Psychedelics such as psilocybin, MDMA and LSD are attracting interest as a treatment for mental health conditions such as depression and post-traumatic stress disorder. In response to this emerging medical research — and public demand  — some states and cities are changing their laws and policies on the supply and use of these mind-altering substances. In some cases, the changes simply make possession enforcement a low priority for police.

Jun 12, 2023 | rand.org | Beau Kilmer |Rajeev Ramchand

Psychedelics such as psilocybin, MDMA (PDF), and LSD are attracting interest as a treatment for mental health conditions such as depression and posttraumatic stress disorder. In response to this emerging medical research—and public demand—some states and cities are changing their laws and policies on the supply and use of these mind-altering substances. In some cases, the changes simply make possession enforcement a low priority for police. But other jurisdictions are going further.